Out-of-state interests spend big on I-1000

Out-of-state money is pouring into the campaigns both for and against Washington Initiative 1000, the measure known by supporters as death with dignity and by opponents as physician-assisted suicide.

PASD staff 'Get Connected' to community

The Phoenixville Area School District welcomed back its staff Wednesday by helping them to "Get Connected" to the Phoenixville community.

Alseres Pharmaceuticals Announces Preclinical Study Results...

Results Presented at the Australian and New Zealand Bone and Mineral Society Annual Meeting HOPKINTON, Mass., Aug.

The year that was: 1967

The topic: upcoming presidential election. The characters: one now in New Jersey, another in California, one here in Illinois and the other now in D.C. Who are these guys? Answer: Chris Bertrand of New Jersey ...

Dolly Team Offers Hope to Victims of Schizophrenia

Scotsman, The By Jenny Haworth IMPROVED treatments for schizophrenia and motor neurone disease could be available within two decades thanks to Scottish experiments using a new type of stem cell.

ACADIA Pharmaceuticals to Present at The Thomas Weisel Partners...

ACADIA Pharmaceuticals Inc. , a biopharmaceutical company utilizing innovative technology to fuel drug discovery and clinical development of novel treatments for central nervous system disorders, today ...

Researchers reprogram cell identities in mice

Talk about an extreme makeover - scientists have transformed one type of cell into another in living mice, a big step toward the goal of growing replacement tissues to treat a variety of diseases.

African-American Hoosier leaders witness history

For veteran African-American political leaders in Indiana, witnessing the historic ascension of Barack Obama as the presidential nominee of the Democratic Party Wednesday was inspiring.

Derringer leads Northridge at Canal

Freshman Michael Derringer continued the hot start to his high school career on Wednesday, leading the Northridge boys cross country team at Canal Winchester.

Nasdaq notes Neurogen nearing delisting

Drug developer Neurogen Corp. was issued a delistment warning from the Nasdaq Stock Market on Tuesday, stating that its common stock failed to meet the minimum per-share price required to remain on the Nasdaq ...